Company news
Delivra Corp news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Harvest One and Delivra Provide Update on Closing Date of Transaction
June 28, 2019
Delivra Announces Q1 2019 Results
May 30, 2019
Delivra Announces Record Sales For 2018
April 11, 2019
Harvest One Acquires Delivra to Strengthen its Medical and Wellness Division
March 4, 2019
Delivra Publishes Positive Results Utilizing its Unique Platform Technology for Topical Doxycycline
February 6, 2019
Delivra publishes positive results utilizing its novel platform technology for Varicose Veins
January 8, 2019
Delivra publishes positive results using its platform technology for topical Advil(TM) (ibuprofen) and Celebrex(TM) (celecoxib)
December 11, 2018
View from the C-Suite: Dr. Joseph Gabriele, Chief Executive Officer, Delivra Corp., tells his company's story. Filmed on November 27, 2018
November 27, 2018
Delivra Achieves Record Third Quarter 2018 Revenues
November 19, 2018
Ernst & Young Names Dr. Joseph Gabriele of Delivra - Entrepreneur of the Year 2018 Ontario Award in the Health Care Category
October 30, 2018
Delivra Announces Stock Option Grant and Postponement of Warrant Expiry
October 15, 2018
Delivra Receiving Interest for its Expertise and Technology for Use in the Cannabis and Pharma Industries
October 1, 2018
Delivra announces appointment of Chief Financial Officer
August 27, 2018
Delivra achieves record second quarter 2018 results
August 20, 2018
Delivra Announces First Quarter Financial Results
May 22, 2018
Delivra Exposes that the Cannabis Market Requires Further Standardization and Rigourous Testing
May 3, 2018
Delivra's Successful Product Development Strategy Yields Product Line Expansions - Including Cannabis-Related Products
April 26, 2018
Delivra successfully demonstrates targeted pain relief with topical ibuprofen
April 24, 2018
Delivra Publishes Pivotal Results on the Cholesterol & Lipid Lowering Agent Berberine
April 18, 2018
Delivra announces 20% sales growth for 2017
April 10, 2018
Delivra Corp. Completes $1,246,498.20 Non-Brokered Financing
April 5, 2018
Delivra Signs Distribution Agreement With NKS Health for Ready to Market Compounded Finished Products to Medical Doctors
February 1, 2018
Delivra signs a joint venture with Intervivo Solutions for a ready to market sleep and anti-anxiety topical therapeutic cream for the animal health industry
January 25, 2018
Delivra develops a revolutionary topical cream utilizing cannabis and opioid molecules for safer delivery in patients with chronic pain and anxiety
January 16, 2018